Skip to main content
NVDA+0.10%AAPL-0.10%GOOGL+0.28%MSFT0.00%AMZN+0.25%TSM-0.26%SPCX+0.03%META-0.36%AVGO+0.15%TSLA-0.14%LLY+0.03%BRK-B0.00%MU+0.09%SKHY+0.02%WMT-0.01%JPM-0.02%AMD-0.06%V0.00%XOM0.00%JNJ+0.02%ASMLa-0.21%MA-0.02%ABBV+0.01%CVX+0.01%INTC-0.43%0700.HK+0.94%COST-0.01%1398.HK-1.50%CSCO-0.01%KO-0.01%ORCL-0.03%UNH-0.01%PG+0.05%BAC+0.01%1816.HK+0.44%3988.HK-0.50%HD-0.06%CAT-0.04%0005.HK-1.04%PM+0.03%HSBA.L-0.36%AP2d-0.15%0857.HK-0.93%0939.HK+0.51%AMAT0.00%GE-0.01%1288.HK-1.94%DELL+0.04%LRCX0.00%NVS-0.02%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%USDPLN0.00%GBPCHF0.00%CHFNOK0.00%GBPUSD0.00%EURPLN0.00%PLNJPY0.00%NZDMXN0.00%GBPCAD0.00%GBPNZD0.00%GBPSGD0.00%NZDCAD0.00%GBPZAR0.00%CADCHF0.00%EURDKK0.00%EURSEK0.00%EURCAD0.00%CHFJPY0.00%EURUSD0.00%EURJPY0.00%EURNZD0.00%GBPAUD0.00%EURNOK0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%AUDCHF0.00%USDSGD0.00%NZDJPY0.00%CADJPY0.00%USDHKD0.00%USDDKK0.00%USDZAR0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD-0.44%ETHUSD+22.11%USDTUSD+0.02%XRPUSD+15.55%SOLUSD+15.78%TRXUSDT+0.12%ZECUSDT+0.23%DOGEUSD+20.76%XMRUSDT-1.25%LINKUSD+23.15%XLMUSD-1.17%BCHUSDT-1.46%LTCUSD+17.32%UNIUSD-1.56%SUIUSD-2.13%HBARUSDT-1.19%TONUSD+36.45%TAOUSDT-0.69%AAVEUSD-0.93%DOTUSDT-1.53%ICPUSDT-1.33%ONDOUSDT-1.55%WLDUSDT-3.31%ARBUSDT-1.86%JUPUSDT-2.29%ATOMUSDT-0.81%INJUSDT+0.36%STXUSDT-3.04%TIAUSDT-1.31%PYTHUSDT+0.76%FETUSDT-2.42%SEIUSDT-3.15%IMXUSDT-1.76%GRTUSDT-2.63%OPUSDT-2.61%IOTAUSDT-1.81%WIFUSDT-3.57%POLUSDT-1.28%AXSUSDT-1.80%EOSUSDT-2.24%FARTCOINUSDT-3.58%DYDXUSDT-4.09%GALAUSDT-2.36%ORDIUSDT-1.78%RONINUSDT-1.68%NOTUSDT0.00%NVDA+0.10%AAPL-0.10%GOOGL+0.28%MSFT0.00%AMZN+0.25%TSM-0.26%SPCX+0.03%META-0.36%AVGO+0.15%TSLA-0.14%LLY+0.03%BRK-B0.00%MU+0.09%SKHY+0.02%WMT-0.01%JPM-0.02%AMD-0.06%V0.00%XOM0.00%JNJ+0.02%ASMLa-0.21%MA-0.02%ABBV+0.01%CVX+0.01%INTC-0.43%0700.HK+0.94%COST-0.01%1398.HK-1.50%CSCO-0.01%KO-0.01%ORCL-0.03%UNH-0.01%PG+0.05%BAC+0.01%1816.HK+0.44%3988.HK-0.50%HD-0.06%CAT-0.04%0005.HK-1.04%PM+0.03%HSBA.L-0.36%AP2d-0.15%0857.HK-0.93%0939.HK+0.51%AMAT0.00%GE-0.01%1288.HK-1.94%DELL+0.04%LRCX0.00%NVS-0.02%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%USDPLN0.00%GBPCHF0.00%CHFNOK0.00%GBPUSD0.00%EURPLN0.00%PLNJPY0.00%NZDMXN0.00%GBPCAD0.00%GBPNZD0.00%GBPSGD0.00%NZDCAD0.00%GBPZAR0.00%CADCHF0.00%EURDKK0.00%EURSEK0.00%EURCAD0.00%CHFJPY0.00%EURUSD0.00%EURJPY0.00%EURNZD0.00%GBPAUD0.00%EURNOK0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%AUDCHF0.00%USDSGD0.00%NZDJPY0.00%CADJPY0.00%USDHKD0.00%USDDKK0.00%USDZAR0.00%GAGUSD0.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%W10.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD-0.44%ETHUSD+22.11%USDTUSD+0.02%XRPUSD+15.55%SOLUSD+15.78%TRXUSDT+0.12%ZECUSDT+0.23%DOGEUSD+20.76%XMRUSDT-1.25%LINKUSD+23.15%XLMUSD-1.17%BCHUSDT-1.46%LTCUSD+17.32%UNIUSD-1.56%SUIUSD-2.13%HBARUSDT-1.19%TONUSD+36.45%TAOUSDT-0.69%AAVEUSD-0.93%DOTUSDT-1.53%ICPUSDT-1.33%ONDOUSDT-1.55%WLDUSDT-3.31%ARBUSDT-1.86%JUPUSDT-2.29%ATOMUSDT-0.81%INJUSDT+0.36%STXUSDT-3.04%TIAUSDT-1.31%PYTHUSDT+0.76%FETUSDT-2.42%SEIUSDT-3.15%IMXUSDT-1.76%GRTUSDT-2.63%OPUSDT-2.61%IOTAUSDT-1.81%WIFUSDT-3.57%POLUSDT-1.28%AXSUSDT-1.80%EOSUSDT-2.24%FARTCOINUSDT-3.58%DYDXUSDT-4.09%GALAUSDT-2.36%ORDIUSDT-1.78%RONINUSDT-1.68%NOTUSDT0.00%
OM

Omnicell, Inc. (OMCL)

NASDAQ • Healthcare

$37.75
+$0.64 (+1.8%)
Market open

Last close at October 23, 2026 at 20:00 UTC

Open$36.87
Previous Close$37.75
Day Range$36.6 - $37.83
Avg. Volume (3M)475.8K
Market Cap$1.7B
P/E Ratio44.4
52 Week Range
$29.09$55
Next EarningsIn 4 daysOct 29, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$312.2M100%
Gross Profitminus cost of goods$152.9M49%
Operating Incomeminus R&D and overhead$32.4M10%
Net Incomeminus taxes and the rest$24.2M8%

In plain terms: out of every $100 in revenue, Omnicell, Inc. keeps $8 as net profit.

Fundamentals & Financials

Revenue (TTM)
$1.2B
Net Income (TTM)
$39M
EPS (TTM)
$0.85
ROA (TTM)
1.96%
Current Ratio
1.64

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-14.9%Q1 2026$0.4
+66.7%Q2 2026$0.55
+101.1%Q3 2026$0.94
Next

Oct 29

in 4 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +101.1%

Omnicell beat expectations on earnings while revenue came in line in the second fiscal quarter of 2026, reported July 30, 2026, with adjusted EPS of $0.94 topping the $0.47 estimate (+101%) as revenue of $312.2 million landed in line with the $310.2 million consensus (+0.6%). Revenue rose 7.4% to about $312.2 million (up from roughly $290.6 million a year ago), led by Connected devices, software licenses, and other at around $149.2 million, up 7.7% year over year, while SaaS and Expert Services contributed roughly $68.6 million, up 7.8%; geographically, the United States remained the largest market at about $281.0 million, up 6.7%, with Rest of world at roughly $31.2 million, up 15.0%. Profitability ran at a gross margin of 49.0% and an operating margin of 10.4%, with gross profit of about $152.9 million and operating income of roughly $32.4 million, and net income increased 330.7% to about $24.3 million (up from roughly $5.6 million a year ago). The company generated operating cash flow of about $69.5 million and repurchased roughly $0.4 million of stock. Next-period consensus calls for EPS of $0.42 on revenue of $304.4 million.

Next report — what to expect

Omnicell, Inc. (OMCL) reports next on October 29, 2026. Wall Street is looking for EPS of $0.42 on revenue of $304.4 million. For trailing context, revenue grew +7.4% year over year last quarter. OMCL has beaten EPS in 7 of 8 most recent quarters, putting focus on any repeat vs consensus.

View full earnings history

About Omnicell, Inc.

Omnicell, Inc. (NASDAQ: OMCL) provides medication management technology and services for healthcare providers, combining automation, software, and pharmacy workflows across the medical information services area. The company generated $1.2 billion of revenue in FY2025 from hospital and health systems solutions, pharmacy platforms, and related support offerings.

Name
Omnicell, Inc.
CEO
Randall A. Lipps
Industry
Healthcare
Year Founded
1992
Employees
3,485

Today's Snapshot

AI-generated

OMCL closed 1.8% above yesterday's close, outperforming a weaker sector. Volume was about half as much again as its usual level.

Trading Volume

Above 10d avg 457.9K

754.6K

vs S&P 500 Today

Outperforming Market

+2.27%

Updated: October 23, 2026 at 20:23 UTC

Technical Indicators

5 Buy1 Neutral2 Sell
OMCL presents a mostly constructive technical picture with the price trading near $37.75 and sitting above the short and medium moving averages while remaining slightly under the 200-day average. Momentum is positive on MACD and CCI, though oscillators show near-overbought readings, and RSI is mildly elevated; ADX near mid-20s points to only a moderate trend. Volume (OBV) is supportive and ATR indicates modest intraday volatility around one dollar. The classic pivot just below the market offers nearby support. Technical takeaway: Buy.
All signals
  • EMA (5 indicators)$35.67 - $38.17
    Buy
  • RSI (14)65.21
    Neutral
  • Stochastic %K (14, 3, 3)87.68
    Sell
  • MACD Level (12, 26)0.70
    Buy
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.